RxDoctor Payments Data

Sebastian Fernandez-Bussy, MD

Pulmonary Disease · Jacksonville, FLNPI 1366527277

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 77.3% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $147,702, 3.8 times the $38,551 reported in 2019. Among pulmonary disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$256,715in general payments, 2019–2025

Across 266 payments — averaging $965.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$199K
  • Olympus Corporation Of The Americas$21K
  • Erbe Elektromedizin GmbH$14K
  • Pulmonx Corporation$12K
  • Cook Incorporated$4K
  • Olympus Latin America, Inc.$4K
  • plus $4K from 5 others
$302,738in research payments, 2019–2025

Across 17 payments — averaging $17,808 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Galvanize Therapeutics, Inc$290K
  • Mauna Kea Technologies, Inc.$13K

What the payments were for

  • Consulting fees$9,9504%
  • Speaking & faculty fees$116,34245%
  • Travel & lodging$59,67223%
  • Food & beverage$7,2803%
  • Education$63,15525%
  • Gifts$3160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical212$198,565
Olympus Corporation Of The Americas27$20,866
Erbe Elektromedizin GmbH3$14,133
Pulmonx Corporation8$11,816
Cook Incorporated1$3,713
Olympus Latin America, Inc.6$3,520
Siemens Medical Solutions USA, Inc.3$3,000
Broncus Medical1$914
Boston Scientific3$140
ERBE USA Inc1$34
Galvanize Therapeutics, Inc1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$256,715 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.

See all pulmonary disease providers in Florida

Medicare billing

Part B allowed, 2024
$84,284
Medicare patients
316
Services billed
768

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate21$439

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →